AR089233A1 - Determinacion de autoanticuerpos en condiciones de baja conductividad y sensibilidad aumentada - Google Patents
Determinacion de autoanticuerpos en condiciones de baja conductividad y sensibilidad aumentadaInfo
- Publication number
- AR089233A1 AR089233A1 ARP120104707A ARP120104707A AR089233A1 AR 089233 A1 AR089233 A1 AR 089233A1 AR P120104707 A ARP120104707 A AR P120104707A AR P120104707 A ARP120104707 A AR P120104707A AR 089233 A1 AR089233 A1 AR 089233A1
- Authority
- AR
- Argentina
- Prior art keywords
- autoantibodies
- low conductivity
- bodies
- determination
- self
- Prior art date
Links
- 230000035945 sensitivity Effects 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 4
- 102000036639 antigens Human genes 0.000 abstract 4
- 108091007433 antigens Proteins 0.000 abstract 4
- 239000012472 biological sample Substances 0.000 abstract 3
- 230000027455 binding Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000007790 solid phase Substances 0.000 abstract 1
- 230000009870 specific binding Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161570211P | 2011-12-13 | 2011-12-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR089233A1 true AR089233A1 (es) | 2014-08-06 |
Family
ID=47630506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP120104707A AR089233A1 (es) | 2011-12-13 | 2012-12-13 | Determinacion de autoanticuerpos en condiciones de baja conductividad y sensibilidad aumentada |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9075069B2 (https=) |
| EP (1) | EP2791675B1 (https=) |
| JP (1) | JP6333731B2 (https=) |
| KR (1) | KR20140104479A (https=) |
| AR (1) | AR089233A1 (https=) |
| AU (1) | AU2012321074B2 (https=) |
| DK (1) | DK2791675T3 (https=) |
| ES (1) | ES2685332T3 (https=) |
| HR (1) | HRP20181118T1 (https=) |
| HU (1) | HUE038441T2 (https=) |
| PL (1) | PL2791675T3 (https=) |
| PT (1) | PT2791675T (https=) |
| TW (1) | TW201339578A (https=) |
| WO (1) | WO2013090636A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013203043B2 (en) | 2013-03-15 | 2016-10-06 | Takeda Pharmaceutical Company Limited | Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs |
| EP3022225B1 (en) * | 2013-07-19 | 2021-09-29 | Board Of Regents Of the University Of Texas System | Transthyretin amyloid-selective and polyreactive catabodies |
| SI24638A (sl) | 2014-02-04 | 2015-08-31 | Univerzitetni kliniÄŤni center Ljubljana | Fluorometrična imunska metoda za določanje protiteles proti dvojnoverižni DNA |
| JP2017528734A (ja) * | 2014-08-08 | 2017-09-28 | アレゲーニー・シンガー リサーチ インスティチュート | 診断用バイオマーカーとしての抗リンパ球自己抗体 |
| CA2990722C (en) | 2015-07-31 | 2022-07-05 | Allegheny-Singer Research Institute | Cell-bound complement activation product assays as companion diagnostics for antibody-based drugs |
| KR20170108203A (ko) | 2016-03-16 | 2017-09-27 | 주식회사 피플바이오 | 응집형-형성 폴리펩타이드의 응집형을 검출하는 방법 |
| CN108169303B (zh) * | 2017-12-07 | 2019-08-20 | 商丘师范学院 | 基于金属有机框架材料作为信号探针的核酸适配体电化学传感器 |
| US12436148B2 (en) | 2018-07-02 | 2025-10-07 | Siemens Healthcare Diagnostics Inc. | Direct immunoassay measurement of autoantibodies |
| JP7268306B2 (ja) * | 2018-08-31 | 2023-05-08 | 東洋紡株式会社 | 生体試料中の測定対象物質を免疫学的に測定する方法 |
| JP7356128B2 (ja) * | 2019-06-07 | 2023-10-04 | 慶應義塾 | 自己免疫疾患の検出剤となるタンパク質複合体、及びその使用 |
| CN113759107A (zh) * | 2021-08-18 | 2021-12-07 | 苏州立禾生物医学工程有限公司 | 生物素标记缓冲液 |
| CN117347616A (zh) * | 2022-06-27 | 2024-01-05 | 菲鹏生物股份有限公司 | 稀释剂、捕获试剂、检测试剂盒和测定方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4259207A (en) | 1979-09-19 | 1981-03-31 | American Hospital Supply Corporation | Suspending medium for immunologic reactions |
| JPS57182168A (en) | 1981-05-02 | 1982-11-09 | Mitsubishi Chem Ind Ltd | Immunochemical reagent |
| US5183735A (en) | 1989-02-27 | 1993-02-02 | Reaads Medical Products, Inc. | Method and diagnostic test kit for detection of anti-dsDNA antibodies |
| US5194585A (en) * | 1989-04-25 | 1993-03-16 | Igen, Inc. | Inhibitors of catalytic antibodies |
| US5981180A (en) | 1995-10-11 | 1999-11-09 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and methods |
| US5763158A (en) | 1997-02-06 | 1998-06-09 | The United States Of America As Represented By The Secretary Of The Army | Detection of multiple antigens or antibodies |
| US6958244B2 (en) | 2002-04-12 | 2005-10-25 | Bruker Biospin Corp. | Low-conductivity buffers for magnetic resonance measurements |
| ES2661168T3 (es) * | 2003-07-12 | 2018-03-27 | Accelerate Diagnostics, Inc. | Biodetección sensible y rápida |
| AU2008286361B2 (en) | 2007-08-13 | 2013-09-26 | Takeda Pharmaceutical Company Limited | IVIG modulation of chemokines for treatment of multiple sclerosis, Alzheimer's disease, and Parkinson's disease |
| AU2009222199A1 (en) | 2008-02-29 | 2009-09-11 | Baxter Healthcare S.A. | Anti-amyloid beta activity of intravenous immunoglobulin (IVIG) in vitro |
| WO2010101213A1 (ja) | 2009-03-05 | 2010-09-10 | デンカ生研株式会社 | 検査試薬及びそれを用いた被検試料中の被測定物の測定方法 |
| KR20110137379A (ko) * | 2009-03-31 | 2011-12-22 | 니뽄 다바코 산교 가부시키가이샤 | 생물학적 시료 중의 ｓｉｔｈ-１의 항체를 검출하는 방법 |
| MX2011012576A (es) | 2009-05-27 | 2012-05-08 | Baxter Int | Metodo para producir una preparacion altamente concentrada de inmunoglobulina de uso subcutaneo. |
| AU2010202125B1 (en) | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
-
2012
- 2012-12-13 AU AU2012321074A patent/AU2012321074B2/en active Active
- 2012-12-13 JP JP2014547447A patent/JP6333731B2/ja active Active
- 2012-12-13 PT PT128209947T patent/PT2791675T/pt unknown
- 2012-12-13 AR ARP120104707A patent/AR089233A1/es unknown
- 2012-12-13 US US13/714,309 patent/US9075069B2/en active Active
- 2012-12-13 PL PL12820994T patent/PL2791675T3/pl unknown
- 2012-12-13 EP EP12820994.7A patent/EP2791675B1/en active Active
- 2012-12-13 HR HRP20181118TT patent/HRP20181118T1/hr unknown
- 2012-12-13 DK DK12820994.7T patent/DK2791675T3/da active
- 2012-12-13 WO PCT/US2012/069587 patent/WO2013090636A1/en not_active Ceased
- 2012-12-13 TW TW101147349A patent/TW201339578A/zh unknown
- 2012-12-13 ES ES12820994.7T patent/ES2685332T3/es active Active
- 2012-12-13 HU HUE12820994A patent/HUE038441T2/hu unknown
- 2012-12-13 KR KR1020147019006A patent/KR20140104479A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012321074A1 (en) | 2013-06-27 |
| EP2791675B1 (en) | 2018-04-25 |
| EP2791675A1 (en) | 2014-10-22 |
| JP6333731B2 (ja) | 2018-05-30 |
| HRP20181118T1 (hr) | 2018-09-21 |
| PT2791675T (pt) | 2018-07-27 |
| WO2013090636A1 (en) | 2013-06-20 |
| ES2685332T3 (es) | 2018-10-08 |
| AU2012321074B2 (en) | 2015-12-03 |
| KR20140104479A (ko) | 2014-08-28 |
| DK2791675T3 (da) | 2018-07-30 |
| HUE038441T2 (hu) | 2018-10-29 |
| TW201339578A (zh) | 2013-10-01 |
| JP2015500502A (ja) | 2015-01-05 |
| US9075069B2 (en) | 2015-07-07 |
| PL2791675T3 (pl) | 2018-10-31 |
| US20130149700A1 (en) | 2013-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR089233A1 (es) | Determinacion de autoanticuerpos en condiciones de baja conductividad y sensibilidad aumentada | |
| MX374652B (es) | Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco. | |
| MX377956B (es) | Sistemas y métodos para maximización de uso de muestras. | |
| CO6551732A2 (es) | Dispositivo portatil de monitorizaciòn de la coagulación y método de evaluación de la respuesta de coagulación | |
| BR112015019614A2 (pt) | análise de imagens e medições de amostras biológicas | |
| EP2839266A4 (en) | METHOD AND SYSTEMS FOR DETECTING AN ANALYTE OR CLASSIFYING A SAMPLE | |
| EP2737090A4 (en) | DEVICE AND METHOD FOR DETECTING ANALYTES | |
| BRPI0915619A2 (pt) | métodos para determinar uma probabilidade de que um sujeito tenha contribuído com material genético para amostra de teste de material genético, para caracterizar amostra de teste de material genético e para determinar se uma pessoa de interesse contribuiu com material genético para uma amostra de teste de material genético, kit para análise de amostra de teste de material genético e sistema para determinar se um sujeito contribuiu com material genético para uma amostra | |
| AR093491A1 (es) | Proteinas de captura de superficie celular recombinantes | |
| EA201490999A1 (ru) | Способ проведения количественных анализов | |
| MX336109B (es) | Formacion de imagenes inmuno-tep de anticuerpos e inmunoconjugados y usos de lo mismo. | |
| EA201391627A1 (ru) | Анализ на наличие лизилоксидазоподобных белков 2 и способы его применения | |
| ZA201402460B (en) | Assembly for determining the presence or absence of an analyte in a blood sample and analysis unit comprising such an assembly | |
| EA201291396A1 (ru) | Способ детекции молекулярных взаимодействий | |
| BR112017017975A2 (pt) | kit para preparação de amostra para detecção de anticorpo monoclonal | |
| EA201700208A1 (ru) | Способ и устройство для обнаружения малярии | |
| EP2835643A4 (en) | METHOD FOR DETECTING OR QUANTITATING ANALYSTS, KIT FOR DETECTING OR QUANTIFYING ANALYSTS AND TEST STRIPS FOR SIDEFLOW CHROMATOGRAPHY FOR DETECTING OR QUANTIFYING ANALYTES | |
| EA201891002A1 (ru) | Иммунологический анализ для определения расщепленного высокомолекулярного кининогена | |
| EP2841926A4 (en) | SAMPLE ANALYSIS DEVICE FOR BIOLOGICAL TESTS | |
| EA201400356A1 (ru) | Иммуноанализ для обнаружения антибиотиков | |
| BR112012015266A2 (pt) | dispositivo configurado para receber uma amostra e método para determinar a presença de um analito em uma amostra | |
| WO2013167727A3 (en) | Method for determining arthritis relapse risk | |
| EA201500377A1 (ru) | Способ обнаружения анализируемого вещества и определение его концентрации с использованием намагничиваемых гранул | |
| SG10201908265UA (en) | L-fabp immunoassay method and assay reagent used in said method | |
| SG10201907690TA (en) | Device and method for detecting target molecules |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |